Posts

Enveda raises $130m to advance AI-driven plant based dr...

The biotech uses its AI platform to discover the therapeutic potential of plant-...

Incyte’s $750M Acquisition Shaken by Key Trial Pause an...

Incyte faced severe difficulties just a few months after purchasing Escient Phar...

71% of Patients in Cybin’s Small Depression Study Are i...

The Canada-based biotechnology company Cybin has announced the results of a Phas...

Pharmanovia signs license agreement for Lindis Biotech’...

Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialis...

Wes Streeting says patients should view data sharing ‘t...

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragme...

KM Biologics’ mpox vaccine approved for emergency use b...

The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 ...

Tris Pharma receives ex-US approvals for ADHD treatments

Tris Pharma has received additional ex-US approvals for its ADHD treatments, Qui...

Veeva Commercial Summit: Increased investment in medica...

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scient...

Parkinson’s disease cases to reach 3.15 million in 7MM ...

Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in ...

EC marketing authorisation granted to Pfizer’s HYMPAVZI...

The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathw...

Leading sales enablement, prospecting and automation pr...

Discover leading sales enablement and marketing intelligence solutions tailored ...

UK life science startups have trouble “scaling up” says...

The UK Minister of State for Science praised the UK’s thriving startup scene at ...

Kura Oncology partners Kyowa Kirin to advance AML treat...

Kura has partnered Kyowa Kirin in a strategic global collaboration for developin...

Roche Partners with Transcription Factor Pioneer Flare ...

Roche has entered a groundbreaking deal worth more than $1.8B with Flare Therape...

AHA 2024: Plozasiran demonstrates promising Phase III r...

During AHA 2024, data were presented from the Phase III trial of plozasiran targ...

AHA 2024: lerodalcibep provides promising results in op...

At AHA 2024, clinical trial results were presented from the ongoing open-label e...